Findings support the World Health Organization’s recommendation of using a two-dose or one-dose HPV vaccine regimen in girls and young women. As many countries are switching to one-dose regimen to scale up the coverage of HPV vaccination, these findings based on nationwide Swedish registries and real-life programs provided high-quality evidence to support such policy changes and decision-making for HPV vaccination programs globally.